Twist Bioscience to Present at the 39th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11th at 5:20 p.m. Eastern Time. The presentation will be webcast live and can be accessed by visiting the “Investor Cale

Click to view original post